Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors a powerful diagnostic and prognostic tool

Investigative Radiology

Volumn 22, Issue 5, 1987, Pages 360-371

  Di Chiro, Giovanni ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Glucose metabolism; Positron emission tomography; Primary cerebral tumors; Tumor grading; Tumor prognosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOISOTOPE;

BRAIN TUMOR; CENTRAL NERVOUS SYSTEM; DIAGNOSIS; DRUG ACCUMULATION; GLIOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NERVOUS SYSTEM; PHARMACOKINETICS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS;

BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; DEOXY SUGARS; DEOXYGLUCOSE; FLUDEOXYGLUCOSE F 18; FLUORINE; GLUCOSE; HUMAN; PROGNOSIS; RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0023195431     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/00004424-198705000-00002     Document Type: Article

References (45)

1. Warburg O. The metabolism of tumors. London: Arnold Constable, 75-327.
2. Dickens F, Simer F. The metabolism of the normal and tumor tissue. Biochem J 1930;24:1301-1326.
3. Warburg O. On the original of cancer cells. Science 1956; 123:309-314.
4. Macbeth RAL, Bekesi JG. Oxygen consumption and anaerobic glycolysis of human malignant and normal tissue. Cancer Res 1962;22:244-248.
5. Weinhouse S. Glycolysis, respiration, and anomalous gene expression in experimental hepatomas. Cancer Res 1972;32:2007-2016.
6. Weber G. Enzymology of cancer cells. N Engl J Med 1977;296:486-493,541-551.
7. Heller IH, Elliott KHC. The metabolism of normal brain and human glomas in relation to cell type and density. Can J Biochem Physiol 1955;33:395-403.
8. Dohr H. Uber die Atmung von menschlichen Hirntumoren and Hirngewebe in vitro. Acta Neurochir 1966;9:195-197.
9. Perria L, Viale G, Ibba F, Andreussi L, Viale E. Istocitochimica deltumori endocranici. Neuopsicologia 1964;20:419-532.
10. Mahaley MS Jr. The in vitro respiration of normal brain and brain tumors. Cancer Res 1966;26:195-197.
11. Wolleman M. Biochemistry of brain tumors. In: LajthaA, ed. Hand book of neuochemistry. New York: Plenum, 1972:503-542.
12. Allen M. Oxidative metabolism of brain tumors. Prog Exp Tumor Res 1 1972;17:192-209.
13. Kirsch WM, Tucker WS, Tabuchi K, et al. The metabolism of the glioblastoma: Pathological correlate. Clin Neurosurg 1978;25: 310-325.
14. Timperly WR. Glycolysis in neuroectodermal tumors. In: Thomas GT, Graham DI, eds. Brain tumors, scientific basis, clinical investigation and current therapy. London: Butterworth, 1980:145-167.
15. Sokoloff L, Reivich M, Kennedy C, et al. The (HC) deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28:897-916.
16. Reivich M, Kuhl D, Wolf A, et al. The (18F) fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 1979;44:127-137.
17. Di Chiro G, DeLaPaz RL, Brooks RA, et al. Glucose utilization of cerebral gliomas measured by 18F fluorodeoxyglucose and positron emission tomography. Neurology 1982;32:1323-1329.
18. Di Chiro G, Brooks RA, Sokoloff L, Patronas NJ, DeLaPaz RL, Smith BH, Komblith PL. Glycolytic rate and histologic grade of human cerebral gliomas: A study with 18F fluorodeoxyglucose and positron emission tomography. In: Heiss WD, Phelps ME, eds. Positron emission tomography of the brain. Berlin, Heidelberg, New York: Springer-Verlag, 1983:181-191.
19. Patronas NJ, Di Chiro G, Brooks RA, et al.18F fluorodeoxyglucose and emission tomography in the evaluation of radiation necrosis of the brain. Radiology; 1982;144:885-889.
20. Patronas JN, Brooks RA, DeLaPaz RL, Smith BH, Kornblith PL, Di Chiro G. Glycolytic rate (PET) and contrast enhancement (CT in human cerebral gliomas). AJNR; 1983;4:533-535.
21. Patronas NJ, Di Chiro G, Smith BH, DeLaPaz RL, Brooks RA, Milam H, Kornblith PL. Depressed cerebellar glucose metabolism in supratentorial tumors. Brain Res 1984;291:93-101.
22. DeLaPaz RL, Patronas NJ, Brooks RA, Smith BH, Kornblith PL, Milam H, Di Chiro G. A positron emission tomography (PET) study of suppression of glucose utilization in cerebral gray matter associated with brain tumor. AJNR 1983;4:826-829.
23. Kornblith PL, Cummins CJ, Smith BH, Brooks RA, Patronas N, DiChiro G. Correlation of experimental and clinical study of metabolism by PET scanning. In: Rosenblum ML, Wilson CB, eds. Progress in experimental brain tumor research. Basel: S. Karger AG, 1984:170-178.
24. Di Chiro G, Oldfield E, Bairamian D, et al. In vivo glucose utilization of CNS tumors of the brain stem and spinal cord. In: Greitz T, Ingvar DM, Widen L, eds. The metabolism of the human brain studied with positron emission tomography. New York: Raven Press, 1985:351-361.
25. Brooks RA, Sank VJ, Friauf WS, Leighton SB, Di Chiro G. Design considerations for positron emission tomography. IEEE Trans Biomed Eng BME 1981;28:158-177.
26. Di Chiro G, Brooks RA, Sank VJ, Friauf WS, Leighton SB, Cascio HE, Yee WJ. The neuro-pet: A new high-resolution 7-slice positron emission tomograph. J Nucl Med 1982;23-59.
27. Sank VJ, Brooks RA, Friauf WS, Leighton SB, Cascio HE, DiChiro G. Performance evaluation and calibration of the neuro-PET scanner. IEEE Trans Nucl Sci 1983;30:636-645.
28. Brooks RA, Friauf WS, Sank VJ, Cascio HE, Leighton SB, Di Chiro G. Initial evaluation of a high resolution positron emission tomograph. In: GreitzT, Ingvar DH, Widen L, eds. The metabolism of the human brain studied with positron emission tomography. New York: Raven Press, 1985:57-68.
29. Huang SC, Hoffman EJ, Phelps ME, Kuhl DE. Quantitation in positron emission computed tomography: 2. Effects of inaccurate attenuation correction. J Comp AssistTomogr 1979;3(6):804-814.
30. Brooks RA. Alternative formula for glucose utilization using labeled deoxyglucose. J Nucl Med 1982;23:538-539.
31. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-2-deoxy-D-glucose: Validation of method. Ann Neurol 1979;5:371-388.
32. Patronas NJ, Di Chiro G, Kufta C, Bairamian D, Kornblith PL, Simon P, Larson SM. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg I985;62: 816-822.
33. Pappius HM, Savaki HE, Fieschi C, et al. Osmotic opening of the blood-brain barrier and local cerebral glucose utilization. Ann Neurol 1979;5:211-219.
34. Pappius HM. Mapping of cerebral functional activity with radioac tive deoxyglucose: Application in studies of traumatized brain. Adv Neurol 1980;28:271-279.
35. Blasberg RG, Groothuis DR, Molnar P. The application of quantita tive autoradiographic measurements in experimental brain tumors. Sem Neurol 1981;1(3):203-223.
36. Blasberg RG, Molnar P, Groothuis D, et al. Simultaneous measure ments of blood flow and metabolism. J Cerebral Blood Flow Metab 1981;1:S68-S69.
37. Brooks RA, Di Chiro G, DeLaPaz RL, Patronas NJ, Shatzman BJ, Weiss GH. Metabolic rates using 18F-deoxyglucose obtained by dynamic positron emission tomographic scanning. Ann Neurol 1982;12:91.
38. Brooks RA, Di Chiro G, Tran AA, Patronas NJ, DeLaPaz RL. Measurements of glucose-6-phosphatase in normal and tumoral brain tissue. Ann Neurol 1982;12:91.
39. Reivich M, Alavi A, Wolf AP, et al. Glucose metabolic rate kinetic model parameter determination in man: The lumped constants and rate constants for (l8F) fluorodeoxyglucose and (11C) deoxyglucose. J Cereb Blood Flow Metab 1981;1:S62.
40. Huang SC, Phelps ME, Hoffman EJ, et al. Noninvasive determina tion of local cerebral metabolic rate of glucose in man. Am J Physiol 1980;238:E69-E82.
41. Crane PD, Pardridge WM, Braun LD, Nyerges AM, Oldendorf WH. The interaction of transport and metabolism on brain glucose utilization: A reevaluation of the lumped constant. J Neurochem 1981;36:1601-1604.
42. Suda S, Shinoara M, Miyaoka M, Kennedy C, Sokoloff L. Local cerebral glucose utilization in hypoglycemia. J Cereb Blood Flow Metab 1981;1:S62.
43. Di Chiro G. Brain imaging of glucose utilization in cerebral tumors. In: L. Sokoloff, ed. Brain imaging and brain function. New York: Raven Press, 1985:185-197.
44. Di Chiro, Brooks RA, Bairamian D, Patronas NJ, Komblith PL, Smith BH, Mansi L. Diagnostic and prognostic value of positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. In: Reivich M, Alavi A, eds. Positron emission tomography. New York: Alan R. Liss, Inc., 1985:291-309.
45. Hatazawa J, Bairamian D, Fishbein DS, Brooks RA, Di Chiro G. Glucose utilization of non-gliomatous cerebral neoplasms as an index of tumor aggressivity. J Nucl Med 1986;27:901.